Cargando…
Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421079/ https://www.ncbi.nlm.nih.gov/pubmed/34499910 http://dx.doi.org/10.1016/j.kint.2021.08.020 |
| _version_ | 1783749005318029312 |
|---|---|
| author | Kant, Sam Geetha, Duvuru |
| author_facet | Kant, Sam Geetha, Duvuru |
| author_sort | Kant, Sam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8421079 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84210792021-09-07 Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis Kant, Sam Geetha, Duvuru Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-11 2021-09-07 /pmc/articles/PMC8421079/ /pubmed/34499910 http://dx.doi.org/10.1016/j.kint.2021.08.020 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Kant, Sam Geetha, Duvuru Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis |
| title | Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis |
| title_full | Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis |
| title_fullStr | Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis |
| title_full_unstemmed | Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis |
| title_short | Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis |
| title_sort | impact of rituximab on humoral response to covid-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421079/ https://www.ncbi.nlm.nih.gov/pubmed/34499910 http://dx.doi.org/10.1016/j.kint.2021.08.020 |
| work_keys_str_mv | AT kantsam impactofrituximabonhumoralresponsetocovid19boostervaccineandantibodykineticsinpatientswithantineutrophilcytoplasmicantibodyvasculitis AT geethaduvuru impactofrituximabonhumoralresponsetocovid19boostervaccineandantibodykineticsinpatientswithantineutrophilcytoplasmicantibodyvasculitis |